AG
EDIT icon

AmeriFlex Group’s Editas Medicine EDIT Stock Holding History

AmeriFlex Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-300
Closed -$1.04K – 1164
2025
Q3 		$1.04K Buy
300
+150
+100% +$419 ﹤0.01% 1002
2025
Q2 		$318 Hold
150
– – ﹤0.01% 1031
2025
Q1 		$174 Hold
150
– – ﹤0.01% 1254
2024
Q4 		$197 Buy
+150
New +$382 ﹤0.01% 1139

Other funds holding EDIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AmeriFlex Group's EDIT Position: Q4 2025 in Review

AmeriFlex Group sold out of Editas Medicine (EDIT) in Q4 2025, closing a stake of 300 shares — an estimated $1.04K sold.

AmeriFlex Group first reported a position in EDIT in Q4 2024 and held it in 4 quarters. The position peaked at $1.04K in Q3 2025. 197 funds tracked by Wall St. Rank hold EDIT as of Q4 2025.

  • AmeriFlex Group reported no remaining Editas Medicine position as of Q4 2025 after selling out during the quarter.
  • AmeriFlex Group sold 300 Editas Medicine shares in Q4 2025, an estimated $1.04K.
  • AmeriFlex Group first reported a position in Editas Medicine in Q4 2024 and held it in 4 quarters.
  • AmeriFlex Group's Editas Medicine position peaked at $1.04K in Q3 2025.
  • 197 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2025.

Based on AmeriFlex Group's 13F filing for Q4 2025, filed 18 Feb 2026.